This collection showcases the journal articles and other publications authored by researchers in the lab of Peter Jones, Ph.D., in the Department of Cell and Developmental Biology at the University of Massachusetts Medical School, prior to the closing of the department in 2017. The Peter Jones lab relocated to the University of Nevado, Reno.

Follow


Publications from 2017

PDF

Large family cohorts of lymphoblastoid cells provide a new cellular model for investigating facioscapulohumeral muscular dystrophy, Takako I. Jones, Charis L. Himeda, Daniel P. Perez, and Peter L. Jones

Publications from 2016

Link

CRISPR/dCas9-mediated transcriptional inhibition ameliorates the epigenetic dysregulation at D4Z4 and represses DUX4-fl in FSH muscular dystrophy, Charis L. Himeda, Takako I. Jones, and Peter L. Jones

Link

Scalpel or Straitjacket: CRISPR/Cas9 Approaches for Muscular Dystrophies, Charis L. Himeda, Takako I. Jones, and Peter L. Jones

PDF

Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD), Takako I. Jones, Megan Parilla, and Peter L. Jones

Publications from 2015

Link

Facioscapulohumeral muscular dystrophy as a model for epigenetic regulation and disease, Charis L. Himeda, Takako I. Jones, and Peter L. Jones

PDF

Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy, Takako I. Jones, Oliver D. King, Charis L. Himeda, Sachiko Homma, Jennifer C. J. Chen, Mary Lou. Beermann, Chi Yan, Charles P. Emerson Jr., Jeffrey B. Miller, Kathryn R. Wagner, and Peter L. Jones

Link

Emerging preclinical animal models for FSHD, Angela Lek, Fedik Rahimov, Peter L. Jones, and Louis M. Kunkel

Publications from 2014

Link

Myogenic Enhancers Regulate Expression of the Facioscapulohumeral Muscular Dystrophy-Associated DUX4 Gene, Charis L. Himeda, Celine Debarnot, Sachiko Homma, Mary Lou Beermann, Jeffrey B. Miller, Peter L. Jones, and Takako I. Jones

Publications from 2013

PDF

Analysis of Myogenic and Candidate Disease Biomarkers in FSHD Muscle Cells, Jennifer C. J. Chen; Takako I. Jones; Oliver D. King; Kendal Hanger; Fedik Rahimov; Sachiko Homma; Mary Lou Beermann; Genila M. Bibat; Jeffrey B. Miller; Louise M. Kunkel; Kathryn R. Wagner; Peter L. Jones; and Charles P. Emerson, Jr.

PDF

Molecular Mechanisms of FSH Muscular Dystrophy Pathogenesis, Peter L. Jones and Takako I. Jones

PDF

Epigenetic variability is a modifier of facioscapulohumeral muscular dystrophy, Takako I. Jones; Chia-Yun Sun; Celine Debarnot; Charis Himeda; Charles P. Emerson, Jr.; and Peter L. Jones

Link

Exome sequencing identifies a novel SMCHD1 mutation in facioscapulohumeral muscular dystrophy 2, Satomi Mitsuhashi, Steven E. Boyden, Elicia A. Estrella, Takako I. Jones, Fedik Rahimov, Timothy W. Yu, Basil T. Darras, Anthony A. Amato, Rebecca D. Folkerth, Peter L. Jones, Louis M. Kunkel, and Peter B. Kang

Publications from 2012

Link

Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis, Takako I. Jones; Jennifer Cj Chen; Fedik Rahimov; Sachiko Homma; Patricia Arashiro; Mary Lou Beermann; Oliver D. King; Jeffrey Boone Miller; Louis M. Kunkel; Charles P. Emerson, Jr.; Kathryn R. Wagner; and Peter L. Jones

PDF

C. elegans PAT-9 is a nuclear zinc finger protein critical for the assembly of muscle attachments, Qian Liu, Takako I. Jones, Rebecca A. Bachmann, Mitchell Meghpara, Lauren Rogowski, Benjamin D. Williams, and Peter L. Jones

PDF

Association of modified cytosines and the methylated DNA-binding protein MeCP2 with distinctive structural domains of lampbrush chromatin, Garry T. Morgan, Peter L. Jones, and Michel Bellini

Publications from 2011

PDF

Temporal uncoupling of the DNA methylome and transcriptional repression during embryogenesis, Ozren Bogdanovic, Steven W. Long, Simon J. van Heeringen, Arie B. Brinkman, Jose Luis Gomez-Skarmeta, Hendrik G. Stunnenberg, Peter L. Jones, and Gert Jan C. Veenstra

PDF

A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processing, Steven W. Long, Jenny Y. Y. Ooi, Peter M. Yau, and Peter L. Jones

Publications from 2009

PDF

FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy, Ryan Wuebbles, Meredith L. Hanel, and Peter L. Jones

Publications from 2008

PDF

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia, Assam El-Osta, Daniella Brasacchio, Dachun Yao, Alessandro Pocai, Peter L. Jones, Robert G. Roeder, Mark E. Cooper, and Michael Brownlee

Publications from 2007

PDF

The tripartite motif (TRIM) of nuclear factor 7 is required for its association with transcription units, Brent Beenders, Peter L. Jones, and Michel Bellini